A liquidity marketplace for the world's intellectual property: EX IX launches

The Problem

Patents are the world's most valuable illiquid asset class. WIPO estimates the global value of intangible assets reached almost $80 trillion in 2024, exceeding the combined GDP of every major economy. Patent licensing generates an estimated $200-500 billion annually. Yet there is no functional secondary market for patent economic rights.

Compare this to equities, bonds, real estate, or commodities. Each has exchanges, clearinghouses, standardized valuation frameworks, and regulatory structures. Patents have none of this. The existing infrastructure is a patchwork of boutique brokerages (Ocean Tomo, ICAP), listing directories (IAM Market, yet2.com), and defensive aggregators (RPX). None provide scalable liquidity.

Multiple attempts to solve this have failed. IPXI, backed by Ocean Tomo and structured as an SEC-regulated exchange, collapsed because patents resist commoditization. Blockchain initiatives like IPwe and Nodalblock attempted tokenization but none reached meaningful scale, facing the same issues of valuation, due diligence cost, and legal uncertainty.

The structural problem has three dimensions:

1. Origination inefficiency. Most inventors lack resources to file globally or build a portfolio strategy.

2. Validation opacity. Before filing, no mechanism tests technical substance. After filing, the 18-month publication window leaves investors blind.

3. Liquidity absence. A patent's economic value is locked inside bilateral deals or litigation settlements. No way to buy or sell a fraction of future revenue without a custom contract.

The Mechanism

EX IX has two integrated sides: the patent factory (origination, filing, prosecution) and the tokenization marketplace (fractional rights, secondary trading).

The factory operates on a cadence model. Patents are identified, validated through simulation, drafted, and filed in coordinated batches. In its first run, EX IX filed 24 patent families in women's health wearables for Edge Assist, a whitespace identified through systematic patent density analysis.

Rather than filing reactively, EX IX identifies technology areas with high commercial potential but low patent density. The women's health wearables space had only 24 existing patents across the entire field when EX IX entered it.

Before filing, each candidate goes through a "prove" stage: a digital twin simulation of the patented technology, rendered in physics-grade software. The Edge Assist thermal digital twin achieved 0.76% MAPE against physical test data.

Once filed, a patent's economic rights can be tokenized. Investors hold as a digital token or a registered paper note. Value follows a four-step curve: Filed (priority locked) to Examination Survived (claims hold up) to First Grant (enforceable right) to US-EU-China (global rights stack).

Beyond the first 24 families, approximately 100 more patents are identified and validated in the pipeline, with 5 upcoming from Energaia Institute covering clean energy and industrial technology.

The Market Opportunity

The intermediated patent transaction market is roughly $2-5 billion annually. The opportunity is not capturing share of this existing market but creating a new category: liquid, fractional patent investment. If even 0.5% of the patent licensing value pool moves through a tokenized marketplace, that represents $1-2.5 billion in annual transaction volume.

The competitive landscape is fragmented: IAM Market (listing directory, no valuation/tokenization), yet2.com (high-touch consulting), Ocean Tomo (full-service IP merchant bank, $10B+ cumulative transactions but every engagement bespoke). None combine origination, validation, and marketplace.

Adoption barriers remain. Investor education is the primary one: patent tokenization is a new asset class. EX IX addresses this by starting with its own originated patents rather than third-party supply.

The Patent Angle

Edge Assist (EXIX001) is the inaugural family: hardware-signed, tamper-proof audit trails for AI decisions on edge devices. Application P00202606645 filed and pending, dual US/EU prosecution underway.

Four elements define the strategy: claim scope (hardware-signature binding, not software), regulatory driver (EU AI Act Article 12 creates a compliance mandate), whitespace advantage (only 24 existing patents in the field), and geographic strategy (US for jury trials and damages, EU for regulatory enforcement).

Long-Term Prospects

The five-to-ten-year trajectory depends on prosecution outcomes (the 50-60% industry norm for independent claim survival is the first real data point on EX IX's origination quality), regulatory development (EU AI Act through 2027-2030 creates a forcing function but also dependence), and marketplace liquidity (Phase 2 opens the rail to third-party IP).

The asymmetric bet is on the 100+ patent pipeline in clean energy. If even a fraction achieve granted status with defensible claims and a carbon pricing regime or clean energy mandate attaches, the portfolio re-rates in a way the entry price does not reflect.

The downside: patent examination is unpredictable, tokenization adoption is unproven at scale, and regulatory tailwinds may not materialize. The IPXI failure is a reminder that structural innovation in patent markets is hard.

Conclusion

EX IX is launching into a $200-500 billion licensing market with no existing liquidity infrastructure, a 24-patent-family first run already filed, and a pipeline of roughly 100 more. The thesis is specific enough to be wrong. If prosecution rates are poor, regulatory mandates shift, or tokenization adoption fails to reach critical mass, the model does not work. But if it works, EX IX has built something that does not exist in any form today. That is the bet, stated plainly.